Your browser doesn't support javascript.
loading
Combination of a drug targeting the cell with a drug targeting the virus controls human immunodeficiency virus type 1 resistance.
Lori, F; Malykh, A G; Foli, A; Maserati, R; De Antoni, A; Minoli, L; Padrini, D; Degli Antoni, A; Barchi, E; Jessen, H; Wainberg, M A; Gallo, R C; Lisziewicz, J.
Affiliation
  • Lori F; Research Institute for Genetic and Human Therapy, Georgetown University, Washington, DC 20007, USA.
AIDS Res Hum Retroviruses ; 13(16): 1403-9, 1997 Nov 01.
Article in En | MEDLINE | ID: mdl-9359660
Subject(s)
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Cells / Acquired Immunodeficiency Syndrome / HIV-1 / Drug Therapy, Combination Type of study: Clinical_trials / Diagnostic_studies / Evaluation_studies Limits: Humans Language: En Journal: AIDS Res Hum Retroviruses Journal subject: SINDROME DA IMUNODEFICIENCIA ADQUIRIDA (AIDS) Year: 1997 Document type: Article Affiliation country: Country of publication:
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Cells / Acquired Immunodeficiency Syndrome / HIV-1 / Drug Therapy, Combination Type of study: Clinical_trials / Diagnostic_studies / Evaluation_studies Limits: Humans Language: En Journal: AIDS Res Hum Retroviruses Journal subject: SINDROME DA IMUNODEFICIENCIA ADQUIRIDA (AIDS) Year: 1997 Document type: Article Affiliation country: Country of publication: